Fat jabs like Ozempic and Mounjaro could also ‘slash risk of UK’s biggest killer’
FAT jabs may lower the risk of the UK’s biggest killer, according to a study of almost 400,000 adults with type 2 diabetes. The research, published in JAMA Neurology, examined two types of ...
Renal & Urology News1h
SGLT2 Inhibitor Use Not Linked to Postoperative Diabetic Ketoacidosis
SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.
Medical Dialogues4h
Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice
Type 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals ...